|
Delayed
Sao Paulo
20:49:00 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 79.65 BRL | -1.30% |
|
+6.48% | +20.76% |
| 11:46am | Goldman Sachs Adjusts Price Target on Amgen to $481 From $475 | MT |
| 10-13 | Goldman Sachs Adjusts Price Target on Amgen to $475 From $450 | MT |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 126,718 | 140,139 | 154,142 | 140,103 | 176,250 | 230,369 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 30.71% | - | - |
| Enterprise Value (EV) 1 | 151,990 | 169,779 | 207,811 | 188,229 | 221,725 | 271,725 | 265,665 | 260,791 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 22.55% | -2.23% | -1.83% |
| P/E | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 27.1x | 24.1x | 23.1x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 20.6x | 16.7x | 13.4x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 2.5x | 2x | 5.36x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 5.91x | 5.7x | 5.51x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 6.97x | 6.58x | 6.24x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 12.5x | 11.9x | 11.7x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 16x | 15x | 14.1x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 24.5x | 17.8x | 16.7x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 4.09% | 5.61% | 5.99% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | 9.52 | 10.09 | 10.66 | 11.12 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | 2.91% | 2.37% | 2.5% | 2.61% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 15.75 | 17.65 | 18.41 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | 66.9% | 64% | 60.4% | 60.4% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 38,975 | 40,395 | 41,810 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,765 | 22,232 | 22,226 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,945 | 17,758 | 18,506 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 8,540 | 9,426 | 9,983 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 41,356 | 35,297 | 30,422 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 426.11 | 426.11 | 426.11 |
| Nbr of stocks (in thousands) | 563,266 | 533,579 | 535,178 | 537,533 | 538,481 | 540,632 | - | - |
| Announcement Date | 07/02/22 | 31/01/23 | 06/02/24 | 04/02/25 | 03/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.58x | 12.46x | 26.12x | 0.57% | 1,077B | |
| 37.53x | 6.26x | 17.55x | 2.1% | 612B | |
| 36.12x | 8.31x | 17.13x | 2.45% | 501B | |
| 113.84x | 6x | 25.7x | 2.32% | 364B | |
| 20.01x | 4.88x | 12.13x | 2.7% | 353B | |
| 20.46x | 5.37x | 13.21x | 2.96% | 278B | |
| 21.15x | 4.27x | 12.26x | 2.07% | 251B | |
| 27.06x | 6.97x | 12.48x | 2.37% | 230B | |
| -44.86x | 6.85x | 26.64x | 2.14% | 190B | |
| Average | 29.54x | 6.82x | 18.14x | 2.19% | 428.5B | |
| Weighted average by Cap. | 35.12x | 7.99x | 19.65x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMGN Stock
- AMGN34 Stock
- Valuation Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
